Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG vs N
Testing Method Category
Testing Method
in house
Testing Method - Additional Info
chemiluminescence immunoassay method compared to commercial ELISA kit (Darui Biotech, China)
Reported Performance
sensitivity: 60.76% (IgM), 92.25% (IgG); specificity: 82.28% (IgM), 97.5% (IgG)
Sample Size
159 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements